• Benzyl-activated Streptavidin Magnetic Beads K1301

  2026-08-22

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, nucleic acids, peptides, antibodies, sugars, and related targets from complex samples. They are appropriate for controlled purification, immunoprecipitation, interaction assays, and screening workflows, but should not be applied directly to live-cell or azide-sensitive systems without buffer exchange and compatibility testing.

• Allosteric PDK4 Inhibitors: Evidence for Compound 8c

  2026-08-22

  The reference study describes an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identifies compound 8c as a lead with nanomolar biochemical activity. Its effects in obese, allergic, and cancer-related models support PDK4 as a cross-disease metabolic target, while also highlighting the need for deeper target-engagement and translational studies.

• FAISL–FAK Proteolysis Drives TNBC Metastasis

  2026-08-21

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby enhancing triple negative breast cancer progression and metastasis. Its combination of transcriptomic discovery, mechanistic validation, and reduction-responsive siRNA delivery defines a regulatory axis with potential value for biomarker development and therapeutic research.

• (-)-Blebbistatin and Cellular Force Signaling

  2026-08-20

  A translational framework for using (-)-Blebbistatin to separate actomyosin-generated force from ligand-independent GABAB receptor activation, with practical guidance for mechanobiology, astrocyte, cardiac, and developmental studies.

• PAD4-IN-2 TFA: Tumor-Targeted NET Research

  2026-08-20

  PAD4-IN-2 TFA, also called Compound 5i TFA, combines PAD4 inhibition with meta-phenylboronic acid targeting to investigate tumor-associated neutrophils, NET biology, and metastasis. This workflow-focused guide covers uptake validation, H3cit measurement, migration assays, immune profiling, formulation, and troubleshooting.

• Ran Lactylation Links Lactate to Astrocyte Polarization

  2026-08-19

  The reference study identifies Ran lactylation at lysine 123 as a non-histone mechanism connecting lactate accumulation with STAT3 nuclear transport and A2-like astrocyte polarization after oxygen-glucose deprivation/reoxygenation. Its combination of metabolic manipulation, lactylome analysis, genetic perturbation, and spinal cord injury models provides a framework for testing SIRT1-dependent metabolic-epigenetic signaling in CNS repair.

• Dual SMAD–Wnt Inhibition for iPSC-Derived RGCs

  2026-08-19

  Chavali and colleagues developed a chemically defined, non-genetic strategy that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells with improved efficiency and reproducibility. The approach produced cultures exceeding 80% RGC purity and enabled magnetic enrichment to nearly 95%, providing a practical foundation for glaucoma modeling and mechanistic studies.

• Carvedilol Phosphate: A Mechanistic IRI Tool

  2026-08-18

  Carvedilol Phosphate can serve as a controlled non-selective beta blocker perturbation in cardiovascular and hepatic ischemia–reperfusion studies. This article connects compound handling with the Arrb2–6-ketoLCA hepatocyte–macrophage axis while distinguishing established evidence from testable experimental hypotheses.

• LG 101506: Practical RXR Modulator Workflows

  2026-08-18

  LG 101506 is a research-ready RXR modulator for connecting nuclear receptor activity with transcriptional, differentiation, and metabolism-focused assays. This workflow-centered guide shows how to prepare, dose, validate, and troubleshoot the compound while using TNBC checkpoint biology as a disciplined translational framework rather than an unsupported efficacy claim.

• Hoechst 33342/PI Kit for Cell Death

  2026-08-17

  Learn how the Hoechst 33342/PI Double Staining Kit converts nuclear morphology and membrane integrity into an interpretable cell-death profile. This article connects Hoechst 33342 propidium iodide staining with mechanistic research on esculin-treated renal cell carcinoma while clarifying assay limitations and complementary validation methods.

• Nintedanib in ATRX-Deficient Glioma Research

  2026-08-17

  Nintedanib (BIBF 1120) enables a practical multi-target workflow for studying VEGFR, FGFR, and PDGFR signaling in cancer and fibrosis models. Its strongest differentiation is the ability to connect angiogenesis inhibition with ATRX-status stratification and temozolomide combination testing.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-08-16

  The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric way to quantify SOD activity in biological fluids through WST-1 reduction driven by xanthine oxidase-generated superoxide. It is suitable for research workflows such as oxidative stress studies, but it should not be used as a diagnostic test or treated as a direct measurement of total reactive oxygen species.

• Pickering Multiple Emulsions for Cancer mRNA Vaccines

  2026-08-15

  Yufei Xia’s 2024 Gunma University dissertation examines water-in-oil-in-water Pickering multiple emulsions as delivery and adjuvant platforms for protein and mRNA cancer vaccines. Its central finding is that calcium phosphate-stabilized emulsions can protect mRNA, support dendritic-cell transfection, avoid the liver-dominant expression pattern associated with the tested LNP comparator, and improve antitumor immune responses in mouse models.

• GSTA1, Glutathione Depletion, and α-Amanitin Toxicity

  2026-08-14

  The reference study identifies GSTA1 as an unexpected driver of α-amanitin-induced liver injury rather than simply a protective antioxidant enzyme. By combining mouse toxicology, multi-omics, protein-interaction assays, and genetic perturbation, the authors link NRF2-dependent GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte damage.

• Metal-Ion-Chelating L-Phe Nanostructures Enhance ICB

  2026-08-14

  A Nature Nanotechnology study developed metal-ion-chelating L-phenylalanine nanostructures that reprogram dendritic-cell ion signaling and remodel immunosuppressive tumour microenvironments. When paired with short-term starvation, these materials improved dendritic-cell maturation, tumour-specific cytotoxic T-cell responses, and sensitivity of breast and colorectal tumour models to immune checkpoint blockade.

7851 records 1/524 page Next 12345 下5页 Last page